Citations

Clear

6273 citation(s) found for "To, Andrew".

ARGONAUT-IV: susceptibility of carbapenemase-producing Klebsiella pneumoniae to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibuten
Jacobs, Michael R. , Good, Caryn E., Abdelhamed, Ayman M., Mack, Andrew R , Bethel, Christopher R. , Marshall, Steven H. , Hujer, Andrea M. , Hujer, Kristine M., Patel, Robin , Fowler, Vance G., Rhoads, Daniel D. , Six, David A. , Papp‐Wallace, Krisztina M. , van Duin, David , Rhoads, Daniel D , Six, David A , Moeck, Greg , Uehara, Tsuyoshi , Papp-Wallace, Krisztina M , Bonomo, Robert A , Patel, Robin , Hujer, Kristine M., Fowler, Vance G. , Uehara, Tsuyoshi , Bonomo, Robert A.

Mayo Clinic

Antimicrobial Agents and Chemotherapy | October 30, 2024 | Volume: 68 | Issue: 12 | Pages: No page available

10.1128/aac.01127-24 | PMID 39475259 Get It

ABSTRACT Ledaborbactam (formerly VNRX-5236), a bicyclic boronate β-lactamase inhibitor with activity against class A, C, and D β-lactamases, is under development as an orally bioavailable etzadroxil prodrug (VNRX-7145) in combination with ceftibuten for the treatment of urinary tract infections. At ceftibuten breakpoints of ≤1 mg/L (EUCAST) and ≤8 mg/L (CLSI), 92.5% and 99.0%, respectively, of 200 carbapenem-resistant Klebsiella pneumoniae isolates, predominantly K. pneumoniae carbapenemase producing, were susceptible to ceftibuten-ledaborbactam (ledaborbactam tested at a fixed concentration of 4 mg/L) compared to 4.5% and 30.5%, respectively, to ceftibuten alone.
The In-Hospital Code Stroke: A Look Back and the Road Ahead
Kuczynski, Andrea M. , Freeman, William D. , Mooney, Lesia , Huang, Josephine F. , Demchuk, Andrew M., Khosravani, Houman , Freeman, William D , Mooney, Lesia H

Mayo Clinic

The Neurohospitalist | October 29, 2024 | Volume: 15 | Issue: 2 | Pages: 124-132

10.1177/19418744241298035 | PMID 39544262 Get It

With increased patient volumes and complexity, stroke occurrence in hospitalized patients has become relatively more common. The process of activating a code stroke in-hospital differs in many institutions. An emergency team-based response to inpatient acute code stroke is warranted, with many protocols modeled similarly to the cardiac arrest response. However, several studies have demonstrated delays in recognition and management of acute stroke in-hospital as compared to those arriving directly to the emergency department (ED). Furthermore, there are several shared challenges with code stroke resuscitation in the ED and the ward, which include the assembly of ad hoc teams and requirement of access to urgent imaging. Delays in activating in-hospital code stroke contributes to increased morbidity, mortality, prolonged hospitalization, and associated health care costs. In the following commentary, we discuss the current landscape of acute in-hospital code stroke protocols, review the differences in neurologic outcomes between inpatient vs ED/out-of-hospital code stroke patients, and propose future directions for in-hospital code stroke paradigms for improved patient outcomes and quality of care.
Airway Mucus Plugs on Chest Computed Tomography Are Associated with Exacerbations in Chronic Obstructive Pulmonary Disease
Wan, Emily S. , Yen, Andrew , Elalami, Rim, Grumley, Scott , Nath, Hrudaya , Wang, Wei , Brouha, Sharon S. , Manapragada, Padma P. , Abozeed, Mostafa , Zahid, Mohd , Ahmed, Asmaa N., Terry, Nina , Ross, James C. , Sonavane, Sushilkumar K. , Kligerman, Seth , Silverman, Edwin K. , Díaz, Alejandro A. , Wan, Emily , Vestbo, Jørgen , Agusti, Alvar , San Jose Estepar, Raul , Cho, Michael H , Diaz, Alejandro A , Yen, Andrew, Aziz, Muhammad Usman , Ahmed, Asmaa N., Nardelli, Pietro , Kim, Victor, Vestbo, Jørgen , Kim, Kangjin , Estépar, Raúl San Jośe , Cho, Michael H.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | October 29, 2024 | Volume: 211 | Issue: 5 | Pages: 814-822

10.1164/rccm.202403-0632oc | PMID 39470402 Get It

Abstract Rationale Acute exacerbations (AEs) of chronic obstructive pulmonary disease (COPD) are associated with significant morbidity and mortality. Whether mucus plugs are associated with prospective exacerbations has not been examined extensively. Objectives To examine associations between mucus plugs on chest computed tomography (CT) and future moderate-to-severe AEs in two independent cohorts with spirometrically-confirmed COPD. Methods Mucus plugs were visually identified on baseline chest computed tomography scans from smokers with Global Initiative for Chronic Obstructive Lung Disease grade 2–4 COPD enrolled in two multicenter cohort studies: ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints) and COPDGene (Genetic Epidemiology of COPD). Associations between ordinal mucus plug score categories (0, 1–2, and ≥3) and prospectively ascertained AEs, defined as worsening respiratory symptoms requiring systemic steroids and/or antibiotics (moderate to severe) and/or emergency room visit or hospitalization (severe), were assessed using multivariable-adjusted zero-inflated Poisson regression; subjects were exacerbation-free at enrollment. Measurements and Main Results Among 3,250 participants in COPDGene (mean age ± SD, 63.7 ± 8.4 yr; FEV1, 50.6 ± 17.8% predicted; 45.1% female) and 1,716 participants in ECLIPSE (age, 63.3 ± 7.1 yr; FEV1, 48.3 ± 15.8% predicted; 36.2% female), 44.4% and 46.0% had mucus plugs, respectively. The incidence rates of AEs were 61.0 (COPDGene) and 125.7 (ECLIPSE) per 100 person-years. Relative to those without mucus plugs, the presence of 1–2 and ≥3 mucus plugs was associated with increased risk (adjusted rate ratio [aRR], 1.07 [95% CI, 1.05–1.09] and 1.15 [1.1–1.2] in COPDGene; aRR, 1.06 [95% CI, 1.02–1.09] and 1.12 [1.04–1.2] in ECLIPSE, respectively) for prospective moderate to severe AEs. The presence of 1–2 and ≥3 mucus plugs was also associated with increased risk for severe AEs during follow-up (aRR, 1.05 [95% CI, 1.01–1.08] and 1.09 [1.02–1.18] in COPDGene; aRR, 1.17 [95% CI, 1.07–1.27] and 1.37 [1.15–1.62] in ECLIPSE, respectively). Conclusions Computed tomography–detected mucus plugs are associated with an increased risk for future COPD AEs.
Implementing the AKI in Care Transitions Program: A Mixed-Methods Study
Ledet, Caroline B., Kattah, Andrea G. , Tinaglia, Angeliki G. , Frazee, Erin N. , May, Heather P. , Ledet, Caroline B., Griffin, Joan M. , Kashani, Kianoush , McCoy, Rozalina G. , Rule, Andrew D.

Mayo Clinic

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.2024wqzmqjmg Get It

Stenosis of the Glomerulotubular Neck Is Associated with Progressive CKD
Aperna, Fnu, Cohen, Eric P. , Đenić, Aleksandar , Gibson, Ian W. , Rule, Andrew D.

Mayo Clinic

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.20246wv0rpfy Get It

COL4A1 Mutation: Hereditary Angiopathy with Nephropathy, Aneurysms, and Muscle Cramps (HANAC) Syndrome, an ADPKD Mimicker
Fichadiya, Harshil, Patel, Vraj , Bentall, Andrew

Mayo Clinic

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.2024qkkjyjkc Get It

Risk Factors for Postevaluation Symptomatic Kidney Stones in Donor Candidates: A 17-Year Follow-Up Study
Keddis, Mira T. , Quillen, Jaxon , Zhang, Nan , Rule, Andrew D.

Mayo Clinic

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.20248vftewpn Get It

AKI in Care Transitions (ACT): A Randomized Controlled Feasibility Trial
Ledet, Caroline B. , Cole, Kristin C., Kattah, Andrea G. , Tinaglia, Angeliki G. , Frazee, Erin N. , May, Heather P. , Cole, Kristin C., Griffin, Joan M. , Herges, Joseph R. , Kashani, Kianoush , McCoy, Rozalina G. , Rule, Andrew D.

Mayo Clinic

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.2024znmpnjh6 Get It

Fewer Podocytes Associate with Progressive CKD Independent of Glomerular Volume and Nephrosclerosis or Clinical Characteristics
Kumar, Mahesh, Aperna, Fnu, Shaik, Afsana Ansari, Alexander, Mariam P., Đenić, Aleksandar , Shaik, Afsana Ansari, Mullan, Aidan F. , Hodgin, Jeffrey B. , Rule, Andrew D.

Mayo Clinic

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.2024pqpwkega Get It

Hepatorenal Syndrome-AKI Reversal and Liver Transplant Rates in Patients Treated with Terlipressin
Belcher, Justin M. , Regner, Kevin R. , Subramanian, Ram, Allegretti, Andrew S. , Cardoza, Sanaz, Mujtaba, Muhammad Ahmad , Wadei, Hani M.

Mayo Clinic

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.2024934zvv6h Get It